1. Home
  2. ANGI vs CRVS Comparison

ANGI vs CRVS Comparison

Compare ANGI & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

HOLD

Current Price

$12.02

Market Cap

488.0M

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$8.06

Market Cap

459.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGI
CRVS
Founded
1995
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
488.0M
459.0M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
ANGI
CRVS
Price
$12.02
$8.06
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$18.20
$13.75
AVG Volume (30 Days)
1.3M
969.0K
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
13.43
N/A
EPS
0.72
N/A
Revenue
$1,057,636,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.89
N/A
P/E Ratio
$16.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.25
$2.54
52 Week High
$20.70
$9.32

Technical Indicators

Market Signals
Indicator
ANGI
CRVS
Relative Strength Index (RSI) 50.25 47.57
Support Level $11.20 $8.49
Resistance Level $11.61 $9.17
Average True Range (ATR) 0.41 0.53
MACD 0.25 -0.07
Stochastic Oscillator 96.98 16.56

Price Performance

Historical Comparison
ANGI
CRVS

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: